U.S. Semi-Autonomous Surgical Robots Market

Market Outlook

By 2035, the U.S. Semi-Autonomous Surgical Robots Market is projected to reach approximately USD 10.25 billion, expanding at a CAGR of 18.23% during 2026–2035. The market is estimated at USD 1.92 billion in 2025, following expansion from approximately USD 0.72 billion in 2021, USD 0.91 billion in 2022, USD 1.17 billion in 2023, and USD 1.49 billion in 2024. Values in this report are expressed in USD billions.

For this report, semi-autonomous surgical robots are defined as robotic or computer-assisted systems in which the physician remains clinically responsible and retains supervisory control, while the platform independently performs or constrains defined portions of the surgical workflow. Relevant capabilities include automated trajectory alignment, active haptic boundaries, automatic depth stopping, supervised bone preparation, robotic waterjet tissue resection, automated positioning, AI-assisted visualization, instrument or camera control, and software-directed execution of preplanned subtasks. This definition is intentionally narrower than the overall robotic-assisted surgery market. FDA guidance emphasizes that conventional robotically assisted surgical systems remain under direct human control, making this distinction critical when sizing the semi-autonomous opportunity.

The market is moving from first-generation robotic assistance toward increasingly intelligent procedural execution. In orthopedics, robotic platforms already combine CT-based or imageless planning with active cutting boundaries and surgeon-supervised preparation. In spine surgery, advanced systems can align instruments to planned trajectories and automatically stop drilling at a predefined depth. In urology, robotic waterjet platforms automate tissue resection according to physician-defined treatment plans. In minimally invasive surgery, AI is beginning to support camera positioning, intraoperative workflow recognition and decision support. These technologies do not remove the surgeon from the procedure; they shift portions of execution from continuous manual manipulation toward supervised automation.

The addressable market is supported by a substantial U.S. surgical infrastructure. The United States has approximately 6,100 hospitals, more than 907,000 staffed hospital beds and nearly 35.7 million annual hospital admissions. In parallel, outpatient surgery continues to decentralize: the number of Medicare-certified ambulatory surgery centers reached approximately 6,436 in 2024, up 2.2% year over year. This creates two distinct procurement environments—high-acuity hospital robotics and compact, workflow-oriented systems designed for outpatient economics.

Historical growth between 2021 and 2025 was supported by rapid adoption of orthopedic robotics, expanding robotic utilization in joint reconstruction, broader availability of navigation-enabled spine platforms, commercialization of robotic waterjet therapy, and accelerating hospital interest in AI-enabled operating-room technologies. The American Joint Replacement Registry’s 2025 report alone analyzed more than 4.4 million hip and knee arthroplasty procedures from 2012 through 2024, demonstrating the enormous procedural base available for robotic penetration in musculoskeletal care.

Over 2026–2035, growth will increasingly depend on how rapidly manufacturers convert robotic systems from navigational aids into supervised execution platforms. The strongest commercial positions are expected to emerge around technologies that improve reproducibility while preserving surgeon authority, can demonstrate measurable workflow benefit, support multiple procedures or implants, and create recurring software, disposable, instrument or service revenue.

Introduction

According to the U.S. Semi-Autonomous Surgical Robots Market Report, surgical robotics is entering a new competitive phase in which the value proposition is shifting from improved visualization and surgeon-controlled articulation toward machine-supported execution of defined surgical tasks.

The strategic distinction is important. Conventional teleoperated robots translate a surgeon’s hand movements into instrument movements and can improve dexterity, visualization and minimally invasive access. Semi-autonomous systems go further by combining imaging, navigation, machine vision, planning software, robotic actuation, sensors and control algorithms to partially automate a task after the clinician defines the objective and confirms the plan. The physician remains responsible for the procedure, but the robot may maintain a trajectory, create a virtual cutting boundary, control depth, position an instrument, execute planned tissue removal or continuously adjust assistance according to intraoperative information.

This model is particularly suited to procedures in which anatomy can be digitally mapped and procedural objectives can be expressed mathematically. Orthopedic joint replacement is currently the strongest commercial example. Stryker reports that more than 2.5 million Mako procedures had been performed globally through 2025, demonstrating that surgeons and hospitals have already accepted software-driven planning and robotic constraint as part of routine care.

Competitive momentum is spreading across other specialties. Stryker’s spine platform incorporates an automatic depth-stop function for planned pedicle preparation and screw placement. PROCEPT’s robotic Aquablation franchise ended 2025 with approximately 718 U.S. robotic systems installed and about 43,300 U.S. procedures performed during the year. Zimmer Biomet’s acquisition of Monogram Technologies gives it a stated pathway toward surgeon-guided semi-autonomous and eventually fully autonomous orthopedic capabilities.

The commercial opportunity should therefore be evaluated as a convergence market rather than a single device category. Revenue comes from capital systems, software licenses, procedure planning, instruments, disposables, maintenance, service contracts, data infrastructure and clinical training. This recurring-revenue dimension is particularly important because health systems increasingly examine robotic acquisition using procedure utilization and lifetime economics rather than capital price alone.

Demographics reinforce the demand environment. Approximately 18.9% of the U.S. population was age 65 or older in 2025, while measured obesity prevalence among U.S. adults was approximately 40.3% during August 2021–August 2023. Aging and obesity increase the burden of osteoarthritis, degenerative spine disease, urologic disease and other conditions that feed high-volume surgical pathways.

The central strategic question for manufacturers is therefore not whether robotics will penetrate more operating rooms. It is which surgical tasks hospitals will permit machines to execute under supervision, which applications create sufficient clinical and economic value to justify automation, and which companies can build enough trust, evidence and workflow integration to obtain recurring utilization after a robot is installed.

Key Market Drivers: What’s Fueling the U.S. Semi-Autonomous Surgical Robots Market Boom?

The first major growth driver is the transition from robotic assistance to reproducible task automation. Hospitals have already invested heavily in navigation, digital planning and robotic-assisted surgery. The incremental commercial opportunity now lies in allowing those platforms to complete tightly bounded procedural steps with less variability. Automated depth control, haptic cutting boundaries, treatment-plan execution and robotic tissue resection can translate preoperative planning more directly into intraoperative action.

Orthopedic surgery is creating the strongest near-term adoption curve. Joint replacement combines high procedure volume, standardized workflows, implant economics and measurable alignment objectives. The American Joint Replacement Registry now contains more than 4.6 million cumulative procedures, providing manufacturers and clinicians with an expanding real-world evidence base around arthroplasty outcomes. Semi-autonomous technologies are well suited to this environment because bone preparation can be planned in three dimensions and physically constrained by robotic systems.

A second driver is hospital demand for procedural consistency. U.S. hospitals are operating within a large but increasingly constrained infrastructure. Staffing pressure, surgeon variability, operating-room utilization and surgical throughput all influence procurement. Semi-autonomous functionality is attractive when it can reduce dependence on repeated manual measurements, maintain predefined boundaries, simplify instrument positioning or create a more standardized procedure across physicians with different levels of robotic experience.

The third driver is the migration of appropriate surgery toward ambulatory settings. Medicare-certified ASCs increased from 5,760 in 2019 to 6,436 in 2024. The outpatient shift changes what buyers expect from surgical robots. Smaller sites are less able to absorb oversized capital platforms, lengthy setup processes, dedicated technical teams and low utilization. This is creating demand for compact robots, handheld systems, modular architectures and business models based on utilization rather than large upfront purchases.

Distalmotion’s U.S. expansion illustrates this strategic shift. DEXTER initially entered the U.S. market for inguinal hernia repair and subsequently added cholecystectomy, gynecologic procedures and additional outpatient indications. Approximately one million cholecystectomies are performed annually in the U.S., with an estimated 60% occurring in outpatient settings, creating a large potential robotics migration opportunity.

A fourth driver is the accelerating role of AI, computer vision and real-time sensing. Semi-autonomy requires the system to understand where an instrument is located relative to anatomy and a surgical plan. Improvements in machine vision, image registration, GPU processing, sensors and intraoperative analytics are making that increasingly practical. Moon Surgical, for example, received FDA clearance for ScoPilot on its Maestro platform in 2025, representing an AI-enhanced intraoperative capability designed around robotic assistance and workflow support.

A fifth driver is the commercial success of procedure-linked robotics. PROCEPT illustrates how robotic capital equipment can generate substantial recurring disposable revenue. The company finished 2025 with 718 U.S. installed robotic systems, up 42% from the prior year, while U.S. procedure volume reached approximately 43,300 procedures for the year. Its model demonstrates why investors and strategic medtech companies value robotics platforms that control a repeatable procedural ecosystem rather than selling capital hardware alone.

A sixth driver is strategic competition among large medtech companies. Stryker, Zimmer Biomet, Smith+Nephew, Medtronic and Johnson & Johnson are expanding robotic, navigation and digital surgery capabilities, while specialized companies are attacking narrower workflows. Zimmer Biomet’s acquisition of Monogram Technologies specifically added a pathway toward semi- and fully autonomous orthopedic robotics. This validates autonomy as a strategic direction rather than a purely experimental technology category.

Finally, surgeon economics and workforce constraints support technologies that allow highly skilled clinicians to operate more consistently and potentially expand procedural capacity. The U.S. employed approximately 54,000 surgeons in 2025, including about 15,500 orthopedic surgeons, while surgeon employment is projected to grow only around 4% through 2035. Technology that improves procedural productivity therefore has strategic value in markets where demand may increase faster than specialist availability.

Innovation in Focus: How Manufacturers Are Raising the Bar?

The most significant innovation is movement toward bounded autonomy rather than unrestricted autonomy. Manufacturers are designing systems that automate specific activities within predefined limits, allowing clinicians to approve the plan and intervene when necessary. This architecture is more compatible with current regulatory expectations, surgeon acceptance and hospital liability frameworks than attempting to remove the physician from the surgical loop.

In orthopedic surgery, haptic and active-boundary technologies are becoming more sophisticated. Systems can incorporate CT data, imageless registration or intraoperative anatomical mapping to create a patient-specific surgical plan. The robotic arm can then prevent the cutting instrument from moving outside predefined boundaries or guide bone preparation according to the approved implant position. This reduces the difference between digital planning and physical execution.

Spine robotics is moving toward similar principles. Stryker’s Copilot Smart Driver can automatically stop when it reaches a preplanned depth, while robotic guidance and tracking maintain alignment with a planned trajectory. These incremental automation functions are strategically important because they demonstrate how manufacturers can introduce autonomy without asking clinicians to surrender overall procedural control.

Robotic tissue removal represents another major innovation category. PROCEPT’s Aquablation technology uses a robotically controlled waterjet to remove prostate tissue according to a physician-defined treatment plan. Approximately 43,300 U.S. procedures were performed on the company’s systems in 2025, and its installed base expanded to 718 systems. This is one of the clearest commercial demonstrations of supervised robotic execution in a high-volume therapeutic workflow.

Handheld and miniaturized robotics are also lowering the infrastructure barrier. THINK Surgical’s TMINI miniature robotic system has continued to receive FDA clearances and expand implant compatibility. Its open-platform architecture can support multiple knee designs, which directly addresses surgeon preference and hospital concerns about becoming locked into one implant ecosystem.

AI will increasingly sit above the mechanical robot. Future differentiation is expected to come from software that can interpret procedural steps, identify anatomical landmarks, predict instrument trajectories, optimize implant positioning, automate image registration and provide contextual guidance. The robot itself becomes one component of a broader surgical intelligence platform.

Manufacturers are also redesigning the economics of robotic adoption. Compact and modular systems reduce physical footprint, while leasing, utilization-based contracts and procedure-linked pricing lower capital barriers. This is especially important in ASCs, where the ability to perform enough reimbursed procedures per week is more important than having the most technologically elaborate platform.

The strongest product roadmaps will therefore combine hardware precision, workflow software, AI-driven intelligence, recurring instruments and measurable economic outcomes. Hospitals are unlikely to adopt autonomous functionality simply because it is technically impressive. They will adopt it when it reduces variability, improves throughput, expands procedural capability or generates better utilization of operating-room assets.

Segmentation Insights

The U.S. Semi-Autonomous Surgical Robots Market is segmented on the basis of component, surgical application, autonomy function, end user, and region.

By Component

Robotic platforms and hardware represent the largest component category and are estimated to account for approximately USD 1.08 billion in 2025. This segment includes robotic arms, handheld robotic systems, navigation carts, imaging interfaces, control units, sensors and specialized instrument-driving systems. Capital equipment remains the primary entry point for new programs, although revenue mix is gradually shifting toward recurring software and procedure-linked products.
Software, AI and digital planning platforms represent the fastest-growing component category. These systems support anatomical segmentation, preoperative planning, automated registration, trajectory optimization, haptic boundaries, workflow recognition and data analytics. Software has high strategic value because advanced autonomy is ultimately controlled by algorithms rather than by the robotic arm itself.
Instruments, accessories and disposables form an increasingly important recurring-revenue segment. Cutting tools, robotic handpieces, procedure-specific instruments, ablation components and other consumables increase lifetime revenue per installed system and align vendor economics with procedure growth.
Service, maintenance and clinical training represent a smaller but durable revenue stream. Semi-autonomous systems require software updates, preventive maintenance, workflow configuration, cybersecurity support and surgeon or staff education. As fleets expand, enterprise service contracts should become more important to procurement.

By Surgical Application

Orthopedic and joint reconstruction surgery is the largest application, estimated to account for approximately 40% of the market in 2025. Robotic assistance is already established in total knee, partial knee and hip replacement, creating a natural pathway toward increasing task autonomy. Stryker reports more than 2.5 million Mako procedures globally, while Smith+Nephew ended 2025 with more than 1,100 CORI systems installed worldwide. Smith+Nephew also reported that 36% of its U.S. knee implants were completed on CORI by the end of 2025.
Spine and neurosurgery are high-growth applications because trajectory planning and instrument guidance are especially compatible with robotic control. Robotic platforms can assist in screw trajectory planning, alignment, navigation and depth control. Globus Medical’s ExcelsiusGPS, Stryker’s spine guidance technologies, Medtronic’s enabling technologies and eCential Robotics’ FDA-cleared spine navigation and robotic-assistance platform make this an increasingly competitive category.
Urology is one of the most commercially validated semi-autonomous applications due to robotic Aquablation. PROCEPT recorded approximately 43,300 U.S. procedures in 2025 and ended the year with 718 U.S. systems installed. Growth will come from increased treatment penetration, higher installed-base utilization and expansion of robotic tissue-treatment technologies.
General and laparoscopic surgery is expected to become a major growth frontier as robotics becomes more accessible outside large tertiary hospitals. Hernia repair, cholecystectomy and bariatric procedures provide large procedural pools. Johnson & Johnson received U.S. FDA market authorization for OTTAVA in July 2026 for multiple upper-abdominal general surgery procedures, increasing competitive intensity in soft-tissue robotics.
Gynecologic surgery is attractive because hysterectomy, salpingo-oophorectomy, endometriosis treatment and pelvic-floor procedures have significant minimally invasive potential. Distalmotion expanded DEXTER’s U.S. gynecologic indications during 2025 and 2026, illustrating growing manufacturer focus on outpatient women’s-health robotics.
Other specialties, including dental, cranial, interventional and image-guided procedures, remain smaller but potentially disruptive niches. Neocis’ Yomi robotic platform provides preoperative planning and robotic navigational guidance for dental implant procedures, while emerging companies are developing robotic assistance for needle placement and other image-guided interventions.

By Autonomy Function

Active constraint and haptic guidance represent the largest autonomy function today. The robot does not independently decide what should be removed; instead, the surgeon approves a plan and the system constrains instrument movement within allowable boundaries. This architecture has proved particularly successful in joint replacement.
Automated planning, registration and navigation represent a foundational software layer. These technologies convert CT, fluoroscopic, ultrasound or intraoperative anatomical data into executable plans and continuously track instruments relative to anatomy.
Automated instrument positioning and depth control are gaining importance in spine, cranial and image-guided procedures. Functions such as automatic stopping at predetermined depth illustrate how repetitive or highly measurable components of surgery can be delegated to the machine while the surgeon supervises.
Supervised tissue resection and ablation are expected to be among the fastest-growing autonomy functions. Robotic waterjet tissue resection and emerging automated bone preparation are commercially significant because the robot directly performs part of the therapeutic intervention according to a physician-defined plan.
AI-assisted intraoperative workflow and visualization are emerging as the software layer with the greatest long-term strategic potential. Camera guidance, procedure recognition, anatomical identification and predictive workflow assistance can make robotic platforms more intelligent without requiring immediate full autonomy.

By End User

Hospitals and integrated delivery networks dominate the market and are estimated to account for approximately 68% of 2025 revenue. Their leadership reflects high procedure volume, capital budgets, complex case mix and ability to spread robotic utilization across multiple surgeons. Large IDNs also increasingly use system-wide contracting and may negotiate robotics alongside implants, instruments, imaging and maintenance.
Academic medical centers are strategically important early adopters because they conduct clinical studies, train surgeons and evaluate emerging levels of autonomy. These centers are particularly influential in spine, orthopedic, urologic, general surgery and experimental digital-surgery workflows.
Ambulatory surgery centers represent the fastest-growing end-user category. The U.S. had approximately 6,436 Medicare-certified ASCs in 2024, and lower-acuity orthopedic, general and gynecologic procedures continue to migrate toward outpatient environments. Compact robotic systems with lower capital requirements and rapid room turnover should gain disproportionate share in this setting.
Specialty surgical centers and physician-led facilities represent a smaller but strategically valuable segment. Robotic joint replacement, spine, dental and procedure-specific platforms can succeed in these environments when the system is tightly aligned with a concentrated surgical service line.

Regional Insights: Where the Market is Growing Fastest

The U.S. Semi-Autonomous Surgical Robots Market is geographically segmented into the South, West, Northeast and Midwest. Regional performance is determined by population growth, surgical procedure volume, orthopedic disease burden, hospital and ASC density, major academic centers, payer mix, surgeon concentration, medical-device ecosystems and willingness of health systems to invest in enabling technologies.

The South is the largest regional market, estimated at approximately USD 0.67 billion in 2025, while the West is projected to record the fastest CAGR of approximately 19.62% through 2035. The Northeast remains an influential early-adoption market for complex systems, while the Midwest benefits from deep orthopedic and medtech infrastructure.

South

The South represents approximately 34.9% of the U.S. market in 2025, with revenue estimated at USD 0.67 billion. The region is projected to reach approximately USD 3.38 billion by 2035, representing a CAGR of about 17.57%.

Texas and Florida are the most important state markets. Texas combines high population growth with major medical centers in Houston, Dallas-Fort Worth, Austin and San Antonio. It also has a substantial ambulatory surgery ecosystem: MedPAC data show approximately 11.2 ASCs per 100,000 Medicare Part B beneficiaries in Texas in 2023. These characteristics make the state attractive for orthopedic, spine, general-surgery and outpatient robotic platforms.

Texas has already become an early commercialization market for next-generation soft-tissue robotics. Memorial Hermann Health System received the first U.S. commercial DEXTER system sale in early 2025, demonstrating the state’s role as a launch market for new robotic architectures.

Florida benefits from one of the country’s largest older adult populations, high joint-replacement demand and a large ASC base. Semi-autonomous orthopedic, urologic and general surgery technologies are particularly well positioned because high procedure volumes can support system utilization and recurring consumable economics.

North Carolina has strong academic and research infrastructure, while Georgia combines population growth with one of the highest concentrations of ASCs relative to Medicare beneficiaries. MedPAC recorded approximately 23.5 ASCs per 100,000 beneficiaries in Georgia, creating a potentially attractive environment for compact robotics designed around outpatient procedures.

Tennessee, Virginia and Maryland provide additional high-value opportunities due to major referral centers, orthopedic programs and technology-oriented health systems. Maryland had the highest measured ASC density in the MedPAC state comparison, at approximately 35 ASCs per 100,000 beneficiaries, although state payment structures, ownership patterns and procedure mix determine the practical robotics opportunity.

Across Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma and West Virginia, adoption is likely to remain concentrated in regional referral centers rather than broadly distributed across community hospitals. High obesity and musculoskeletal disease burden support procedure demand, but capital availability and specialist access remain uneven. The most attractive products in these states will be platforms that improve access without requiring the infrastructure of a tertiary academic OR.

West

The West represented an estimated USD 0.50 billion in 2025, or approximately 26.0% of the national market, and is projected to reach USD 3.00 billion by 2035. This implies a CAGR of roughly 19.62%, making it the fastest-growing U.S. region.

California is the region’s primary market and one of the most strategically important surgical robotics states nationally. Its importance extends beyond procedure demand: California hosts robotic surgery manufacturers, AI developers, venture-backed medical-device companies and academic health systems that frequently participate in early commercialization.

Moon Surgical maintains a U.S. presence in California and has introduced its Maestro platform into U.S. clinical settings. THINK Surgical is also based in California and continues to expand its TMINI robotic ecosystem. Intuitive Surgical’s large Northern California presence further strengthens the state’s surgical robotics talent, training and supplier ecosystem, even though conventional da Vinci systems remain primarily surgeon-controlled rather than semi-autonomous.

California is also attractive because hospitals are more accustomed to evaluating data-driven medical technologies. AI-assisted planning, digital operating-room integration, surgical analytics and automated workflow functions are therefore likely to gain commercial acceptance earlier than in less technology-intensive markets.

Arizona, Nevada, Colorado and Utah should record above-average adoption due to population growth, expanding orthopedic demand and significant ambulatory infrastructure. MedPAC reported ASC densities of approximately 16.8 per 100,000 Medicare beneficiaries in Arizona, 15.1 in Nevada, 14.1 in Colorado and 14.2 in Utah, all above many larger Eastern states. That infrastructure supports deployment of compact robotic platforms where total knee replacement and other procedures shift outside traditional inpatient hospitals.

Washington and Oregon are comparatively smaller but sophisticated health-system markets with strong adoption of digital health, navigation and minimally invasive technology. Idaho and Montana have smaller absolute procedure volumes, making mobile, flexible or multi-specialty robotic architectures more commercially appropriate than highly specialized high-capital systems.

The West’s main strategic advantage is the proximity between clinical customers and technology development. Manufacturers can iterate software, collect workflow feedback and partner with technology companies more readily, which should accelerate adoption of AI-based autonomy through the forecast period.

Northeast

The Northeast accounted for an estimated USD 0.42 billion in 2025, or approximately 21.9% of the national market, and is projected to reach approximately USD 2.13 billion by 2035, corresponding to a CAGR of roughly 17.63%.

New York is the region’s largest state market because of its population, major academic systems and high-acuity surgical programs. Advanced spine, neurosurgical, urologic and minimally invasive robotics are particularly relevant in large New York health systems, where complex referral cases support premium technology.

Massachusetts is disproportionately important relative to its population. Boston’s concentration of academic medical centers, biomedical engineering, robotics research and venture investment makes the state an influential validation market. New robotic systems that achieve strong clinician acceptance in Massachusetts can gain credibility with procurement committees nationally.

Pennsylvania and New Jersey provide substantial orthopedic, joint replacement, spine and ambulatory procedure volumes. New Jersey also has a relatively dense ASC environment, with MedPAC recording approximately 16.5 ASCs per 100,000 Medicare beneficiaries in 2023.

Connecticut, Rhode Island, New Hampshire, Maine and Vermont represent smaller absolute markets. However, concentrated health systems can support enterprise adoption when technologies offer multi-specialty utilization or strong procedural economics.

The Northeast is likely to remain particularly important for clinical evidence generation. Procurement committees in the region tend to demand strong comparative evidence, surgeon training plans, cybersecurity documentation and economic justification. As semi-autonomous technology moves into more clinically consequential tasks, validation at major Northeastern academic centers will become an important commercialization asset.

Midwest

The Midwest represented approximately USD 0.33 billion in 2025, or roughly 17.2% of the U.S. market, and is projected to reach approximately USD 1.74 billion by 2035, representing a CAGR near 18.09%.

The region has particular strategic importance in orthopedics. Indiana is home to a major orthopedic-device cluster, while Minnesota has deep medtech and surgical technology expertise. Zimmer Biomet’s presence in Indiana and the broader orthopedic ecosystem around the state increase its importance in the development and commercialization of robotic joint-replacement technologies.

Zimmer Biomet’s acquisition of Monogram Technologies in October 2025 is especially relevant to the region. The company stated that the transaction creates a pathway toward surgeon-guided semi- and fully autonomous orthopedic technologies, linking a major Midwest orthopedic incumbent directly to the next autonomy cycle.

Ohio is another critical state due to its major health systems and advanced surgical programs. Cleveland Clinic performed the first U.S. commercial procedure using Medtronic’s FDA-cleared Hugo robotic-assisted surgery system in February 2026, underscoring Ohio’s role as an early adopter of new surgical platforms.

Illinois provides a large procedure base centered around Chicago, while Michigan and Wisconsin contribute substantial orthopedic and spine volumes. Iowa, Kansas, Nebraska, North Dakota and South Dakota are smaller markets but could benefit from technologies that support procedural standardization and reduce dependence on highly specialized teams.

The Midwest is unlikely to match the West in AI-driven experimentation, but it is exceptionally important for commercialization of orthopedic robotics because manufacturers can connect robotic platforms directly with implant portfolios, surgeon relationships and established hospital contracting structures.

Key Market Players

The U.S. Semi-Autonomous Surgical Robots competitive landscape is becoming increasingly diverse. Large medtech companies have advantages in capital contracting, implant pull-through, hospital relationships and service infrastructure, while specialized robotics companies can innovate faster around specific procedural tasks.

Competition is expected to move away from pure hardware performance toward the degree of useful automation a platform can safely deliver. The most defensible systems will combine proprietary planning algorithms, clinical data, instruments, digital workflow, installed-base utilization and recurring procedure revenue.

Some of the key and strategically relevant participants in the U.S. semi-autonomous and advanced surgical robotics ecosystem include:

Stryker
Zimmer Biomet
Smith+Nephew
THINK Surgical
PROCEPT BioRobotics
Globus Medical
Medtronic
Johnson & Johnson MedTech
Intuitive Surgical
CMR Surgical
Distalmotion
Moon Surgical
Mendaera
Brainlab
eCential Robotics
Neocis
KARL STORZ / Asensus Surgical
Corin Group
Monteris Medical
Renishaw
Accuray
Vicarious Surgical
ForSight Robotics

Stryker currently has one of the strongest positions in semi-autonomous orthopedics because Mako combines patient-specific planning with robotic-arm assistance and haptic technology. More than 2.5 million Mako procedures had been completed globally through 2025. Its move into spine with automatic depth-stop functionality demonstrates a strategy of extending intelligent robotic control across musculoskeletal procedures.

Zimmer Biomet is building a broad robotics portfolio around ROSA and acquired Monogram Technologies specifically to expand toward semi- and fully autonomous orthopedic solutions. At the time the Monogram transaction was announced, ROSA was approaching 2,000 installations worldwide.

Smith+Nephew has built substantial momentum with CORI. By the end of 2025, more than 1,100 CORI systems had been installed worldwide, and the company reported strong utilization in U.S. knee procedures. Its strategy emphasizes compact robotics suitable for both hospitals and ASCs.

THINK Surgical is differentiated by its miniature TMINI platform and emphasis on implant choice. PROCEPT is differentiated by high procedural automation in Aquablation. Globus Medical and eCential Robotics are relevant in spine navigation and robotic assistance, while Neocis applies robotic guidance to dental procedures.

Intuitive Surgical remains the broader surgical robotics benchmark even though its core da Vinci systems are not categorized here as semi-autonomous revenue unless specific automated functionality falls within this report’s definition. Its market influence remains enormous: approximately 3.153 million da Vinci procedures were performed worldwide in 2025, and its installed base reached approximately 11,106 systems. This installed infrastructure sets the workflow and usability standard against which newer robotic platforms are compared.

Recent Developments

The competitive environment changed materially during 2024–2026 as several new robotic platforms entered or expanded in the United States.

In July 2026, Johnson & Johnson received FDA De Novo market authorization for its OTTAVA Robotic Surgical System for multiple upper-abdominal general surgery procedures. This marks a significant competitive entry by one of the world’s largest surgical technology companies and increases pressure on incumbent soft-tissue robotics suppliers.

In February 2026, the first U.S. commercial procedure using Medtronic’s FDA-cleared Hugo robotic-assisted surgery system was performed at Cleveland Clinic. Medtronic subsequently pursued additional U.S. indications in general and gynecologic surgery, indicating its intention to build a broader domestic robotic franchise.

In 2025, Zimmer Biomet completed its acquisition of Monogram Technologies, creating a stated pathway toward surgeon-guided semi-autonomous and fully autonomous orthopedic robotics. The transaction is strategically important because it combines an emerging automation technology with a large orthopedic implant and hospital-sales platform.

PROCEPT continued to demonstrate strong commercial adoption of robotic Aquablation. The company ended 2025 with 718 U.S. robotic systems installed, up approximately 42%, and reported 43,300 U.S. procedures for the year. These utilization levels show how a procedure-specific robotic platform can achieve recurring economic scale.

CMR Surgical has also entered the U.S. competitive landscape. Versius received initial FDA De Novo authorization in 2024, and Versius Plus received U.S. clearance for cholecystectomy. By early 2026, more than 45,000 patients had been treated globally using the Versius platform, giving CMR a substantial international clinical base as it expands in the U.S.

Distalmotion accelerated DEXTER’s U.S. rollout across inguinal hernia repair, cholecystectomy and gynecologic surgery, followed by additional clearances in 2026. Its first U.S. sale was completed with Memorial Hermann in Texas, and AdventHealth subsequently acquired multiple systems. This signals meaningful buyer interest in robotic platforms specifically designed around outpatient workflow and smaller-footprint economics.

Moon Surgical continued development of Maestro and received clearance for AI-enhanced ScoPilot functionality in 2025. Mendaera received FDA clearance in July 2025 for a handheld robotic system that guides precise placement of interventional devices relative to ultrasound imaging, further broadening the definition of medical robotics beyond traditional large operating-room systems.

These developments collectively point toward a market where competition will no longer be defined solely by whether a hospital owns a surgical robot. The next competitive question is how much clinically useful intelligence, automation and procedural execution each installed platform can deliver.

Conclusion

The U.S. Semi-Autonomous Surgical Robots Market Size & Share is positioned for rapid expansion from an estimated USD 1.92 billion in 2025 to approximately USD 10.25 billion by 2035, representing an aggressive 18.23% CAGR during 2026–2035.

Growth will be driven by the transition from surgeon-controlled robotic assistance toward supervised task automation, particularly in orthopedic bone preparation, spine trajectory guidance, robotic tissue resection, instrument positioning, image-guided intervention and AI-supported minimally invasive surgery.

Orthopedic robotics will remain the largest commercial segment in the near term because it combines high procedure volumes, strong implant economics and anatomy that can be translated into precise digital plans. Urology has already demonstrated the commercial viability of robotically executed tissue treatment, while spine surgery provides a natural environment for trajectory and depth automation. General and gynecologic surgery represent the next major volume opportunities as compact systems and alternative business models increase robotic penetration into outpatient care.

Hospitals and IDNs will remain the largest buyers, but ASCs are expected to gain share faster than any other end-user category. With more than 6,400 Medicare-certified ASCs already operating in the U.S., manufacturers that can deliver compact footprints, short setup times, lower capital intensity and high procedure utilization will have a significant addressable growth channel.

Regionally, the South will remain the largest market because of its population, hospital infrastructure and procedural volumes. The West is expected to expand fastest due to its medical technology ecosystem, AI adoption and high concentration of outpatient surgical infrastructure. The Northeast will remain important for evidence generation and premium technology adoption, while the Midwest will play a central role in orthopedic robotics commercialization.

The competitive advantage will increasingly shift from the company with the most robotic arms to the company with the strongest procedural intelligence stack. Clinical planning, machine vision, real-time sensing, bounded automation, instruments, recurring software and outcomes data will collectively determine value.

For hospitals and investors evaluating this market, the fundamental issue is therefore not whether autonomous functionality can technically be added to surgery. The relevant questions are which surgical tasks can be automated safely, which functions create enough measurable benefit to change purchasing behavior, which systems achieve sustained utilization after installation, and how rapidly regulatory and clinical acceptance moves from assistance toward supervised execution.

Companies that solve those questions while maintaining surgeon control, strong clinical evidence and credible hospital economics are positioned to capture the largest share of the U.S. semi-autonomous surgical robotics opportunity through 2035.

TABLE OF CONTENT

1. U.S. Semi-Autonomous Surgical Robots Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Semi-Autonomous Surgical Robotics Technology Boundary
1.6.1. Surgeon-Controlled Robotic Assistance
1.6.2. Supervised Semi-Autonomous Execution
1.6.3. Bounded and Task-Specific Autonomy
1.6.4. Distinction from Fully Autonomous Surgical Systems
1.7. Stakeholder Analysis
1.7.1. Surgical Robotics Manufacturers
1.7.2. Robotic Components, Sensors, and Actuation Suppliers
1.7.3. AI, Computer Vision, and Surgical Software Developers
1.7.4. Hospitals and Integrated Delivery Networks
1.7.5. Academic Medical Centers and Robotic Surgery Programs
1.7.6. Ambulatory Surgery Centers and Specialty Surgical Facilities
1.7.7. Surgeons, Clinical Teams, and Robotic Program Directors
1.7.8. Group Purchasing Organizations and Distribution Partners
1.7.9. Payers, Regulators, and Health Technology Decision-Makers

What this section provides: This section defines the U.S. semi-autonomous surgical robots market boundary, autonomy criteria, study methodology, assumptions, and stakeholder ecosystem, enabling clients to understand exactly which robotic technologies and revenue streams are included in the market assessment.

2. U.S. Semi-Autonomous Surgical Robots Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size, 2025 and 2035 (US$ Billion)
2.8. Forecast CAGR Analysis, 2026–2035
2.9. High-Growth Surgical Applications
2.10. High-Growth Autonomy Functions
2.11. Hospital and ASC Adoption Outlook
2.12. Key Investment and Commercial Opportunity Areas

What this section provides: This section provides executives with a concise view of market size, CAGR, historical development, adoption trajectory, leading applications, autonomy trends, customer segments, and the highest-priority commercial opportunities through 2035.

3. U.S. Semi-Autonomous Surgical Robots Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Transition from Robotic Assistance to Supervised Task Automation
3.1.2. Growth in Robotic Orthopedic and Joint Reconstruction Procedures
3.1.3. Rising Demand for Surgical Precision and Reproducibility
3.1.4. Expansion of Robotic Spine and Image-Guided Surgery
3.1.5. Growth of Robotic Aquablation and Automated Tissue Resection
3.1.6. Increasing Hospital Investment in Digital Operating Rooms
3.1.7. Expansion of Robotic Procedures into Ambulatory Surgery Centers
3.1.8. Increasing Integration of AI, Computer Vision, and Real-Time Sensing

3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Acquisition and Lifecycle Costs
3.2.2. Limited Clinical Evidence for Higher Levels of Surgical Autonomy
3.2.3. Surgeon Acceptance and Trust Barriers
3.2.4. Complex Training and Credentialing Requirements
3.2.5. Hospital Capital Budget Competition
3.2.6. Cybersecurity and Software Reliability Concerns
3.2.7. Regulatory Uncertainty Around Increasing Levels of Autonomy

3.3. Opportunities and Their Impact Analysis
3.3.1. Semi-Autonomous Orthopedic Bone Preparation
3.3.2. Automated Spine Trajectory Guidance and Depth Control
3.3.3. AI-Assisted Intraoperative Workflow Recognition
3.3.4. Robotic Tissue Resection and Ablation
3.3.5. Miniaturized and Handheld Surgical Robotics
3.3.6. ASC-Optimized Robotic Platforms
3.3.7. Multi-Specialty Semi-Autonomous Robotic Platforms
3.3.8. Software and Recurring Procedure Revenue Models

3.4. Challenges and Their Impact Analysis
3.4.1. Demonstrating Clinical Superiority Versus Conventional Robotic Assistance
3.4.2. Integration with Existing OR Infrastructure
3.4.3. Interoperability with Imaging and Navigation Systems
3.4.4. Liability Allocation Between Surgeon, Hospital, and Manufacturer
3.4.5. Maintaining Surgeon Override and Human-in-the-Loop Control

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Installed Base and Procedure Utilization Analysis
3.9. Recurring Revenue and Procedure Economics Analysis
3.10. Surgeon Learning Curve and Training Economics
3.11. Hospital Robotics Program ROI Framework

What this section provides: This section evaluates the clinical, technological, financial, regulatory, and workflow factors shaping adoption and enables clients to identify where semi-autonomous robotics can create measurable clinical value and commercially sustainable hospital economics.

4. U.S. Semi-Autonomous Surgical Robots Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospital and ASC Buyers
4.2.3. Bargaining Power of Component and Technology Suppliers
4.2.4. Substitution Risk from Conventional Surgery and Surgeon-Controlled Robotics
4.2.5. Competitive Rivalry

4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Surgical Robotics Component Supply Landscape
4.6. Impact of AI, Computer Vision, and Surgical Digitalization
4.7. Application & Innovation Landscape
4.8. FDA Regulatory Framework for Robotic and Computer-Assisted Surgical Systems
4.9. FDA Considerations for AI/ML-Enabled and Semi-Autonomous Functions
4.10. CMS Reimbursement and Procedure Economics Landscape
4.11. Medical Device Cybersecurity Requirements
4.12. Import/Export Restrictions & Tariff Impact
4.13. Government Initiatives Supporting Medical Robotics and AI
4.14. Impact of Escalating Geopolitical and Semiconductor Supply Risks
4.15. Hospital Value Analysis Committee Decision Framework
4.16. Robotic System Capital Approval and Utilization Threshold Analysis
4.17. Technology Obsolescence and Upgrade-Cycle Analysis

What this section provides: This section gives clients a complete view of the regulatory, reimbursement, technology, pricing, supply-chain, cybersecurity, and procurement environment influencing commercialization of semi-autonomous surgical robots in the United States.

5. U.S. Semi-Autonomous Surgical Robots Market – By Component

5.1. Overview
5.1.1. Segment Share Analysis, By Component, 2025 & 2035 (%)
5.1.2. Robotic Platforms and Hardware
5.1.2.1. Robotic Arms and Manipulators
5.1.2.2. Miniature and Handheld Robotic Systems
5.1.2.3. Robotic Control Units and Consoles
5.1.2.4. Sensors, Tracking, and Actuation Hardware
5.1.2.5. Integrated Imaging and Navigation Hardware

5.1.3. Software, AI, and Digital Planning Platforms
5.1.3.1. Preoperative Planning Software
5.1.3.2. Intraoperative Navigation Software
5.1.3.3. AI and Computer Vision Software
5.1.3.4. Robotic Control and Autonomy Algorithms
5.1.3.5. Surgical Analytics and Data Platforms

5.1.4. Instruments, Accessories, and Disposables
5.1.4.1. Robotic Surgical Instruments
5.1.4.2. Cutting and Bone Preparation Instruments
5.1.4.3. Tissue Resection and Ablation Consumables
5.1.4.4. Tracking and Registration Accessories
5.1.4.5. Procedure-Specific Disposable Components

5.1.5. Services, Maintenance, and Clinical Training
5.1.5.1. Preventive Maintenance
5.1.5.2. Software Upgrades and Support
5.1.5.3. Surgeon Training and Credentialing Support
5.1.5.4. Clinical Implementation Services

What this section provides: This section identifies which hardware, software, instruments, disposables, and service components contribute most to market revenue and where recurring revenue opportunities are expected to expand through 2035.

6. U.S. Semi-Autonomous Surgical Robots Market – By Surgical Application

6.1. Overview
6.1.1. Segment Share Analysis, By Surgical Application, 2025 & 2035 (%)

6.1.2. Orthopedic and Joint Reconstruction Surgery
6.1.2.1. Total Knee Arthroplasty
6.1.2.2. Partial Knee Arthroplasty
6.1.2.3. Total Hip Arthroplasty
6.1.2.4. Other Orthopedic Procedures

6.1.3. Spine and Neurosurgery
6.1.3.1. Pedicle Screw Placement
6.1.3.2. Spinal Fusion Procedures
6.1.3.3. Cranial and Stereotactic Procedures
6.1.3.4. Other Image-Guided Neurological Procedures

6.1.4. Urology
6.1.4.1. Robotic Aquablation
6.1.4.2. Prostate Surgery
6.1.4.3. Kidney and Urinary Tract Procedures
6.1.4.4. Other Urologic Procedures

6.1.5. General and Laparoscopic Surgery
6.1.5.1. Hernia Repair
6.1.5.2. Cholecystectomy
6.1.5.3. Colorectal Surgery
6.1.5.4. Bariatric Surgery
6.1.5.5. Other General Surgery Procedures

6.1.6. Gynecologic Surgery
6.1.6.1. Hysterectomy
6.1.6.2. Salpingo-Oophorectomy
6.1.6.3. Endometriosis Procedures
6.1.6.4. Other Gynecologic Procedures

6.1.7. Other Surgical Applications
6.1.7.1. Dental and Maxillofacial Surgery
6.1.7.2. Image-Guided Interventional Procedures
6.1.7.3. Ophthalmic Surgery
6.1.7.4. Other Emerging Applications

What this section provides: This section identifies the surgical specialties and procedure categories generating the strongest addressable opportunity for semi-autonomous robotics and compares their procedure volumes, adoption maturity, automation potential, and growth outlook.

7. U.S. Semi-Autonomous Surgical Robots Market – By Autonomy Function

7.1. Overview
7.1.1. Segment Share Analysis, By Autonomy Function, 2025 & 2035 (%)

7.1.2. Active Constraint and Haptic Guidance
7.1.2.1. Virtual Surgical Boundaries
7.1.2.2. Haptic Bone Preparation
7.1.2.3. Collision and Restricted-Zone Prevention

7.1.3. Automated Planning, Registration, and Navigation
7.1.3.1. Patient-Specific Surgical Planning
7.1.3.2. Automated Anatomical Registration
7.1.3.3. Trajectory Optimization
7.1.3.4. Intraoperative Navigation

7.1.4. Automated Instrument Positioning and Depth Control
7.1.4.1. Robotic Instrument Alignment
7.1.4.2. Automated Depth Stop
7.1.4.3. Trajectory Maintenance
7.1.4.4. Automated Camera and Instrument Positioning

7.1.5. Supervised Tissue Resection and Ablation
7.1.5.1. Automated Bone Preparation
7.1.5.2. Robotic Waterjet Tissue Resection
7.1.5.3. Robot-Assisted Ablation
7.1.5.4. Other Supervised Therapeutic Execution

7.1.6. AI-Assisted Intraoperative Workflow and Visualization
7.1.6.1. Surgical Phase Recognition
7.1.6.2. Anatomical Landmark Identification
7.1.6.3. AI-Assisted Camera Guidance
7.1.6.4. Predictive Workflow Assistance
7.1.6.5. Real-Time Decision Support

What this section provides: This section evaluates the specific autonomous and semi-autonomous functions creating clinical value, allowing clients to identify which technologies are moving from basic guidance toward supervised execution of surgical tasks.

8. U.S. Semi-Autonomous Surgical Robots Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)

8.1.2. Hospitals and Integrated Delivery Networks
8.1.2.1. Large Tertiary and Quaternary Hospitals
8.1.2.2. Community Hospitals
8.1.2.3. Multi-Hospital Integrated Delivery Networks

8.1.3. Academic Medical Centers
8.1.3.1. Research and Teaching Hospitals
8.1.3.2. Clinical Trial and Early-Adopter Centers
8.1.3.3. Robotic Surgery Training Centers

8.1.4. Ambulatory Surgery Centers
8.1.4.1. Orthopedic ASCs
8.1.4.2. Multi-Specialty ASCs
8.1.4.3. Hospital-Owned ASCs
8.1.4.4. Physician-Owned ASCs

8.1.5. Specialty Surgical Centers and Physician-Led Facilities
8.1.5.1. Orthopedic Specialty Centers
8.1.5.2. Spine Surgery Centers
8.1.5.3. Urology Centers
8.1.5.4. Dental and Other Specialty Facilities

What this section provides: This section explains which provider settings are driving robotic capital investment and procedure utilization, with particular focus on hospital systems, academic early adopters, and rapidly expanding ambulatory surgery applications.

9. U.S. Semi-Autonomous Surgical Robots Market – By Procurement & Commercial Model

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement & Commercial Model, 2025 & 2035 (%)

9.1.2. Direct Capital Purchase
9.1.2.1. Single-System Purchases
9.1.2.2. Multi-System Hospital Purchases
9.1.2.3. Capital Replacement and Upgrade Purchases

9.1.3. Leasing and Rental Models
9.1.3.1. Operating Lease
9.1.3.2. Capital Lease
9.1.3.3. Flexible Equipment Rental

9.1.4. Procedure-Based and Pay-Per-Use Models
9.1.4.1. Procedure-Linked Payments
9.1.4.2. Consumable-Driven Placement Models
9.1.4.3. Minimum Procedure Commitment Models

9.1.5. Integrated Delivery Network and Enterprise Contracts
9.1.5.1. Multi-Hospital Enterprise Agreements
9.1.5.2. System-Wide Robotics Standardization
9.1.5.3. Enterprise Service and Software Contracts

9.1.6. Strategic Bundling and Portfolio-Based Procurement
9.1.6.1. Robot and Implant Bundling
9.1.6.2. Robot, Instrument, and Disposable Bundling
9.1.6.3. Navigation, Imaging, and Robotics Bundling
9.1.6.4. GPO-Supported Procurement

What this section provides: This section explains how U.S. hospitals and ASCs finance and acquire semi-autonomous robotic systems, including capital purchases, leasing, procedure-based pricing, enterprise agreements, and portfolio bundling strategies.

10. U.S. Semi-Autonomous Surgical Robots Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Robotic Procedure Volume Analysis
10.1.4. Regional Installed Base and Surgical Infrastructure Analysis
10.1.5. Regional Hospital and ASC Adoption Analysis
10.1.6. Regional Capital Procurement and Reimbursement Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Autonomy Function, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

What this section provides: This section delivers granular regional and state-level market intelligence covering all 50 U.S. states, allowing clients to compare semi-autonomous robotics adoption, hospital and ASC opportunity, procedure concentration, procurement behavior, and commercial potential across the West, Northeast, South, and Midwest.

11. U.S. Semi-Autonomous Surgical Robots Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking
11.2.1. Robotic Platform Breadth
11.2.2. Level of Procedural Autonomy
11.2.3. Installed Base
11.2.4. Procedure Utilization
11.2.5. Software and AI Capabilities
11.2.6. Recurring Revenue Model
11.2.7. Hospital and ASC Penetration

11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players

11.4. Company Profiles

11.4.1. Stryker
11.4.2. Zimmer Biomet
11.4.3. Smith+Nephew
11.4.4. THINK Surgical
11.4.5. PROCEPT BioRobotics
11.4.6. Globus Medical
11.4.7. Medtronic
11.4.8. Johnson & Johnson MedTech
11.4.9. Intuitive Surgical
11.4.10. CMR Surgical
11.4.11. Distalmotion
11.4.12. Moon Surgical
11.4.13. Mendaera
11.4.14. Brainlab
11.4.15. eCential Robotics
11.4.16. Neocis
11.4.17. KARL STORZ / Asensus Surgical
11.4.18. Corin Group
11.4.19. Monteris Medical
11.4.20. Renishaw
11.4.21. Accuray
11.4.22. Vicarious Surgical
11.4.23. ForSight Robotics

11.5. Company Profile Assessment Framework
11.5.1. Company Overview
11.5.2. U.S. Surgical Robotics Portfolio
11.5.3. Semi-Autonomous Technology Capabilities
11.5.4. U.S. Installed Base and Commercial Presence
11.5.5. Surgical Application Positioning
11.5.6. AI, Software, and Digital Surgery Strategy
11.5.7. Financial and Commercial Positioning
11.5.8. FDA Regulatory Status and Pipeline
11.5.9. Strategic Partnerships and Collaborations
11.5.10. Mergers, Acquisitions, and Investments
11.5.11. Recent Developments

What this section provides: This section provides competitor benchmarking, company-level technology positioning, autonomy capabilities, installed-base intelligence, procedure exposure, commercial strategies, regulatory pipelines, and strategic direction across established and emerging surgical robotics companies.

12. U.S. Semi-Autonomous Surgical Robots Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario

12.2. Disruptive Technologies Impact
12.2.1. AI-Powered Surgical Intelligence
12.2.2. Advanced Computer Vision and Anatomical Recognition
12.2.3. Haptic Boundaries and Bounded Autonomy
12.2.4. Automated Surgical Planning and Registration
12.2.5. Real-Time Sensor Fusion
12.2.6. Automated Tissue Resection and Ablation
12.2.7. Miniaturized and Handheld Robotics
12.2.8. Digital Twins and Patient-Specific Surgical Simulation
12.2.9. Autonomous Camera and Instrument Positioning
12.2.10. Cloud-Connected Surgical Analytics

12.3. Evolution from Assistance to Semi-Autonomy
12.3.1. Level 0 – Manual Surgery
12.3.2. Level 1 – Robotic Assistance
12.3.3. Level 2 – Task Autonomy
12.3.4. Level 3 – Conditional Autonomy
12.3.5. Long-Term Pathway Toward Higher Autonomy

12.4. Emerging Business Trends
12.4.1. Robotics-as-a-Service Models
12.4.2. Pay-Per-Procedure Economics
12.4.3. Implant-Robotics Ecosystem Bundling
12.4.4. ASC-First Robotic Commercialization
12.4.5. Software-Driven Recurring Revenue
12.4.6. Multi-Specialty Robotic Platforms

12.5. Business Opportunities for Startups and Existing Players
12.6. Investment Prioritization Matrix
12.7. Technology Readiness and Commercialization Matrix
12.8. Surgical Specialty Opportunity Matrix
12.9. Market White-Space Analysis

What this section provides: This section prepares clients for the next phase of surgical automation by evaluating disruptive technologies, adoption scenarios, emerging business models, autonomy progression, white-space opportunities, and investment priorities through 2035.

13. U.S. Semi-Autonomous Surgical Robots Market: Strategic Recommendations

13.1. Recommendations for Surgical Robotics Manufacturers
13.2. Recommendations for Hospitals and Integrated Delivery Networks
13.3. Recommendations for Ambulatory Surgery Centers
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for AI and Surgical Software Developers
13.6. Recommendations for Component and Technology Suppliers
13.7. Recommendations for Distributors and Channel Partners
13.8. Recommendations for New Entrants and Startups
13.9. U.S. Go-to-Market Strategy Considerations
13.10. Hospital Capital Procurement Strategy
13.11. ASC Commercialization Strategy
13.12. Clinical Evidence and Surgeon Adoption Strategy
13.13. FDA Regulatory Strategy Considerations
13.14. Product Positioning and Portfolio Expansion Guidance
13.15. Pricing and Recurring Revenue Strategy
13.16. Partnership, M&A, and Technology Licensing Opportunities

What this section provides: This section converts market intelligence into practical strategic recommendations for manufacturers, hospitals, ASCs, investors, technology suppliers, and new entrants seeking growth, differentiation, stronger adoption, and sustainable commercialization in U.S. semi-autonomous surgical robotics.

14. U.S. Semi-Autonomous Surgical Robots Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition and Autonomy Classification Limitation
14.3. Data Use Limitation
14.4. Forecasting Limitation
14.5. Regulatory and Clinical Data Limitation
14.6. Legal Disclaimer
14.7. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s scope boundaries, semi-autonomous robotics classification methodology, data limitations, forecast assumptions, regulatory considerations, and legal limitations applicable to interpretation and use of the market research.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Semi-Autonomous Surgical Robots Market: Market Definition and Scope
TABLE 3: U.S. Semi-Autonomous Surgical Robots Market: Research Methodology Framework
TABLE 4: U.S. Semi-Autonomous Surgical Robots Market: Key Assumptions
TABLE 5: U.S. Semi-Autonomous Surgical Robots Market: Market Ecosystem Overview
TABLE 6: U.S. Semi-Autonomous Surgical Robots Market: Stakeholder Analysis
TABLE 7: U.S. Semi-Autonomous Surgical Robots Market: Semi-Autonomous Surgical Robotics Technology Boundary
TABLE 8: U.S. Semi-Autonomous Surgical Robots Market: Executive Summary Snapshot, 2025
TABLE 9: U.S. Semi-Autonomous Surgical Robots Market: Analyst Viewpoint Summary
TABLE 10: U.S. Semi-Autonomous Surgical Robots Market: Market Attractiveness Index
TABLE 11: U.S. Semi-Autonomous Surgical Robots Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 12: U.S. Semi-Autonomous Surgical Robots Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Semi-Autonomous Surgical Robots Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 14: U.S. Semi-Autonomous Surgical Robots Market: High-Growth Opportunity Areas
TABLE 15: U.S. Semi-Autonomous Surgical Robots Market: Drivers; Impact Analysis
TABLE 16: U.S. Semi-Autonomous Surgical Robots Market: Restraints; Impact Analysis
TABLE 17: U.S. Semi-Autonomous Surgical Robots Market: Opportunities; Impact Analysis
TABLE 18: U.S. Semi-Autonomous Surgical Robots Market: Challenges; Impact Analysis
TABLE 19: U.S. Semi-Autonomous Surgical Robots Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Semi-Autonomous Surgical Robots Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Semi-Autonomous Surgical Robots Market: Hospital Capital Procurement Behavior Matrix
TABLE 22: U.S. Semi-Autonomous Surgical Robots Market: Installed Base and Procedure Utilization Analysis
TABLE 23: U.S. Semi-Autonomous Surgical Robots Market: Recurring Revenue and Procedure Economics Analysis
TABLE 24: U.S. Semi-Autonomous Surgical Robots Market: Surgeon Learning Curve and Training Economics
TABLE 25: U.S. Semi-Autonomous Surgical Robots Market: Hospital Robotics Program ROI Framework
TABLE 26: U.S. Semi-Autonomous Surgical Robots Market: PESTEL Analysis
TABLE 27: U.S. Semi-Autonomous Surgical Robots Market: Porter’s Five Forces Analysis
TABLE 28: U.S. Semi-Autonomous Surgical Robots Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 29: U.S. Semi-Autonomous Surgical Robots Market: Value Chain Analysis
TABLE 30: U.S. Semi-Autonomous Surgical Robots Market: Supply Chain Analysis
TABLE 31: U.S. Semi-Autonomous Surgical Robots Market: Surgical Robotics Component Supply Landscape
TABLE 32: U.S. Semi-Autonomous Surgical Robots Market: AI, Computer Vision, and Surgical Digitalization Impact
TABLE 33: U.S. Semi-Autonomous Surgical Robots Market: Application & Innovation Landscape
TABLE 34: U.S. Semi-Autonomous Surgical Robots Market: FDA Regulatory Framework Analysis
TABLE 35: U.S. Semi-Autonomous Surgical Robots Market: FDA Considerations for AI/ML-Enabled and Semi-Autonomous Functions
TABLE 36: U.S. Semi-Autonomous Surgical Robots Market: CMS Reimbursement and Procedure Economics Landscape
TABLE 37: U.S. Semi-Autonomous Surgical Robots Market: Medical Device Cybersecurity Requirements
TABLE 38: U.S. Semi-Autonomous Surgical Robots Market: Import/Export Restrictions & Tariff Impact
TABLE 39: U.S. Semi-Autonomous Surgical Robots Market: Hospital Value Analysis Committee Decision Framework
TABLE 40: U.S. Semi-Autonomous Surgical Robots Market: Robotic System Capital Approval and Utilization Threshold Analysis
TABLE 41: U.S. Semi-Autonomous Surgical Robots Market: Component Snapshot, 2025
TABLE 42: Segment Dashboard; Definition and Scope, by Component
TABLE 43: U.S. Semi-Autonomous Surgical Robots Market, by Component, 2021–2035 (US$ Billion)
TABLE 44: U.S. Semi-Autonomous Surgical Robots Market: Segment Share Analysis, by Component, 2025 & 2035 (%)
TABLE 45: U.S. Semi-Autonomous Surgical Robots Market: Robotic Platforms and Hardware Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Semi-Autonomous Surgical Robots Market: Software, AI, and Digital Planning Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Semi-Autonomous Surgical Robots Market: Instruments, Accessories, and Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Semi-Autonomous Surgical Robots Market: Services, Maintenance, and Clinical Training Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Semi-Autonomous Surgical Robots Market: Surgical Application Snapshot, 2025
TABLE 50: Segment Dashboard; Definition and Scope, by Surgical Application
TABLE 51: U.S. Semi-Autonomous Surgical Robots Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 52: U.S. Semi-Autonomous Surgical Robots Market: Segment Share Analysis, by Surgical Application, 2025 & 2035 (%)
TABLE 53: U.S. Semi-Autonomous Surgical Robots Market: Orthopedic and Joint Reconstruction Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Semi-Autonomous Surgical Robots Market: Spine and Neurosurgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Semi-Autonomous Surgical Robots Market: Urology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Semi-Autonomous Surgical Robots Market: General and Laparoscopic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Semi-Autonomous Surgical Robots Market: Gynecologic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Semi-Autonomous Surgical Robots Market: Other Surgical Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Semi-Autonomous Surgical Robots Market: Autonomy Function Snapshot, 2025
TABLE 60: Segment Dashboard; Definition and Scope, by Autonomy Function
TABLE 61: U.S. Semi-Autonomous Surgical Robots Market, by Autonomy Function, 2021–2035 (US$ Billion)
TABLE 62: U.S. Semi-Autonomous Surgical Robots Market: Segment Share Analysis, by Autonomy Function, 2025 & 2035 (%)
TABLE 63: U.S. Semi-Autonomous Surgical Robots Market: Active Constraint and Haptic Guidance Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Semi-Autonomous Surgical Robots Market: Automated Planning, Registration, and Navigation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Semi-Autonomous Surgical Robots Market: Automated Instrument Positioning and Depth Control Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Semi-Autonomous Surgical Robots Market: Supervised Tissue Resection and Ablation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Semi-Autonomous Surgical Robots Market: AI-Assisted Intraoperative Workflow and Visualization Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Semi-Autonomous Surgical Robots Market: End User Snapshot, 2025
TABLE 69: Segment Dashboard; Definition and Scope, by End User
TABLE 70: U.S. Semi-Autonomous Surgical Robots Market, by End User, 2021–2035 (US$ Billion)
TABLE 71: U.S. Semi-Autonomous Surgical Robots Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 72: U.S. Semi-Autonomous Surgical Robots Market: Hospitals and Integrated Delivery Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Semi-Autonomous Surgical Robots Market: Academic Medical Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Semi-Autonomous Surgical Robots Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Semi-Autonomous Surgical Robots Market: Specialty Surgical Centers and Physician-Led Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Semi-Autonomous Surgical Robots Market: Procurement & Commercial Model Snapshot, 2025
TABLE 77: Segment Dashboard; Definition and Scope, by Procurement & Commercial Model
TABLE 78: U.S. Semi-Autonomous Surgical Robots Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 79: U.S. Semi-Autonomous Surgical Robots Market: Segment Share Analysis, by Procurement & Commercial Model, 2025 & 2035 (%)
TABLE 80: U.S. Semi-Autonomous Surgical Robots Market: Direct Capital Purchase Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Semi-Autonomous Surgical Robots Market: Leasing and Rental Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Semi-Autonomous Surgical Robots Market: Procedure-Based and Pay-Per-Use Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Semi-Autonomous Surgical Robots Market: Integrated Delivery Network and Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Semi-Autonomous Surgical Robots Market: Strategic Bundling and Portfolio-Based Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Semi-Autonomous Surgical Robots Market: Regional Snapshot, 2025
TABLE 86: Segment Dashboard; Definition and Scope, by Region
TABLE 87: U.S. Semi-Autonomous Surgical Robots Market, by Region, 2021–2035 (US$ Billion)
TABLE 88: U.S. Semi-Autonomous Surgical Robots Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 89: U.S. Semi-Autonomous Surgical Robots Market: Regional Robotic Procedure Volume and Installed Base Analysis, 2025
TABLE 90: U.S. Semi-Autonomous Surgical Robots Market: Regional Hospital and ASC Adoption Analysis, 2025
TABLE 91: West Region U.S. Semi-Autonomous Surgical Robots Market: Regional Overview and Trends
TABLE 92: West Region U.S. Semi-Autonomous Surgical Robots Market: Key Manufacturers and Procurement Ecosystem
TABLE 93: West Region U.S. Semi-Autonomous Surgical Robots Market, by State, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Semi-Autonomous Surgical Robots Market, by Component, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Semi-Autonomous Surgical Robots Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Semi-Autonomous Surgical Robots Market, by Autonomy Function, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Semi-Autonomous Surgical Robots Market, by End User, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Semi-Autonomous Surgical Robots Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 99: California Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 100: Washington Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 101: Arizona Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 102: Colorado Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 103: Oregon Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 104: Utah Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 105: Nevada Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 106: New Mexico Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 107: Idaho Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 108: Montana Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 109: Wyoming Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 110: Alaska Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 111: Hawaii Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 112: Northeast Region U.S. Semi-Autonomous Surgical Robots Market: Regional Overview and Trends
TABLE 113: Northeast Region U.S. Semi-Autonomous Surgical Robots Market: Key Manufacturers and Procurement Ecosystem
TABLE 114: Northeast Region U.S. Semi-Autonomous Surgical Robots Market, by State, 2021–2035 (US$ Billion)
TABLE 115: Northeast Region U.S. Semi-Autonomous Surgical Robots Market, by Component, 2021–2035 (US$ Billion)
TABLE 116: Northeast Region U.S. Semi-Autonomous Surgical Robots Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 117: Northeast Region U.S. Semi-Autonomous Surgical Robots Market, by Autonomy Function, 2021–2035 (US$ Billion)
TABLE 118: Northeast Region U.S. Semi-Autonomous Surgical Robots Market, by End User, 2021–2035 (US$ Billion)
TABLE 119: Northeast Region U.S. Semi-Autonomous Surgical Robots Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 120: New York Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 121: Massachusetts Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 122: New Jersey Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 123: Pennsylvania Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 124: Connecticut Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 125: Maine Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 126: Vermont Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 127: New Hampshire Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 128: Rhode Island Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 129: Delaware Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 130: South Region U.S. Semi-Autonomous Surgical Robots Market: Regional Overview and Trends
TABLE 131: South Region U.S. Semi-Autonomous Surgical Robots Market: Key Manufacturers and Procurement Ecosystem
TABLE 132: South Region U.S. Semi-Autonomous Surgical Robots Market, by State, 2021–2035 (US$ Billion)
TABLE 133: South Region U.S. Semi-Autonomous Surgical Robots Market, by Component, 2021–2035 (US$ Billion)
TABLE 134: South Region U.S. Semi-Autonomous Surgical Robots Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. Semi-Autonomous Surgical Robots Market, by Autonomy Function, 2021–2035 (US$ Billion)
TABLE 136: South Region U.S. Semi-Autonomous Surgical Robots Market, by End User, 2021–2035 (US$ Billion)
TABLE 137: South Region U.S. Semi-Autonomous Surgical Robots Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 138: Texas Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 139: Florida Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 140: Georgia Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 141: North Carolina Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 142: Tennessee Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 143: South Carolina Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 144: Alabama Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 145: Mississippi Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 146: Louisiana Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 147: Arkansas Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 148: Kentucky Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 149: Oklahoma Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 150: Virginia Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 151: Maryland Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 152: West Virginia Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 153: Midwest Region U.S. Semi-Autonomous Surgical Robots Market: Regional Overview and Trends
TABLE 154: Midwest Region U.S. Semi-Autonomous Surgical Robots Market: Key Manufacturers and Procurement Ecosystem
TABLE 155: Midwest Region U.S. Semi-Autonomous Surgical Robots Market, by State, 2021–2035 (US$ Billion)
TABLE 156: Midwest Region U.S. Semi-Autonomous Surgical Robots Market, by Component, 2021–2035 (US$ Billion)
TABLE 157: Midwest Region U.S. Semi-Autonomous Surgical Robots Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region U.S. Semi-Autonomous Surgical Robots Market, by Autonomy Function, 2021–2035 (US$ Billion)
TABLE 159: Midwest Region U.S. Semi-Autonomous Surgical Robots Market, by End User, 2021–2035 (US$ Billion)
TABLE 160: Midwest Region U.S. Semi-Autonomous Surgical Robots Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 161: Illinois Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 162: Ohio Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 163: Michigan Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 164: Minnesota Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 165: Indiana Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 166: Wisconsin Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 167: Missouri Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 168: Iowa Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 169: Kansas Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 170: Nebraska Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 171: North Dakota Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 172: South Dakota Semi-Autonomous Surgical Robots Market Size, Forecast and Segment Outlook, 2021–2035 (US$ Billion)
TABLE 173: U.S. Semi-Autonomous Surgical Robots Market: Competitive Landscape Snapshot, 2025
TABLE 174: U.S. Semi-Autonomous Surgical Robots Market: Key Company Market Share Analysis, 2025
TABLE 175: U.S. Semi-Autonomous Surgical Robots Market: Company Positioning Matrix
TABLE 176: U.S. Semi-Autonomous Surgical Robots Market: Robotic Platform Breadth Benchmarking
TABLE 177: U.S. Semi-Autonomous Surgical Robots Market: Autonomy Capability Benchmarking
TABLE 178: U.S. Semi-Autonomous Surgical Robots Market: Installed Base and Procedure Utilization Benchmarking
TABLE 179: U.S. Semi-Autonomous Surgical Robots Market: Software, AI, and Recurring Revenue Benchmarking
TABLE 180: U.S. Semi-Autonomous Surgical Robots Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 181: Stryker: Company Profile
TABLE 182: Zimmer Biomet: Company Profile
TABLE 183: Smith+Nephew: Company Profile
TABLE 184: THINK Surgical: Company Profile
TABLE 185: PROCEPT BioRobotics: Company Profile
TABLE 186: Globus Medical: Company Profile
TABLE 187: Medtronic: Company Profile
TABLE 188: Johnson & Johnson MedTech: Company Profile
TABLE 189: Intuitive Surgical: Company Profile
TABLE 190: CMR Surgical: Company Profile
TABLE 191: Distalmotion: Company Profile
TABLE 192: Moon Surgical: Company Profile
TABLE 193: Mendaera: Company Profile
TABLE 194: Brainlab: Company Profile
TABLE 195: eCential Robotics: Company Profile
TABLE 196: Neocis: Company Profile
TABLE 197: KARL STORZ / Asensus Surgical: Company Profile
TABLE 198: Corin Group: Company Profile
TABLE 199: Monteris Medical: Company Profile
TABLE 200: Renishaw: Company Profile
TABLE 201: Accuray: Company Profile
TABLE 202: Vicarious Surgical: Company Profile
TABLE 203: ForSight Robotics: Company Profile
TABLE 204: U.S. Semi-Autonomous Surgical Robots Market: Future Market Scenario Analysis, 2026–2035
TABLE 205: U.S. Semi-Autonomous Surgical Robots Market: Disruptive Technologies Impact Matrix
TABLE 206: U.S. Semi-Autonomous Surgical Robots Market: Evolution from Assistance to Semi-Autonomy Framework
TABLE 207: U.S. Semi-Autonomous Surgical Robots Market: Emerging Business Trends
TABLE 208: U.S. Semi-Autonomous Surgical Robots Market: Business Opportunities for Startups and Existing Players
TABLE 209: U.S. Semi-Autonomous Surgical Robots Market: Investment Prioritization Matrix
TABLE 210: U.S. Semi-Autonomous Surgical Robots Market: Technology Readiness and Commercialization Matrix
TABLE 211: U.S. Semi-Autonomous Surgical Robots Market: Surgical Specialty Opportunity Matrix
TABLE 212: U.S. Semi-Autonomous Surgical Robots Market: Market White-Space Analysis
TABLE 213: U.S. Semi-Autonomous Surgical Robots Market: Strategic Recommendations for Surgical Robotics Manufacturers
TABLE 214: U.S. Semi-Autonomous Surgical Robots Market: Strategic Recommendations for Hospitals and Integrated Delivery Networks
TABLE 215: U.S. Semi-Autonomous Surgical Robots Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 216: U.S. Semi-Autonomous Surgical Robots Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 217: U.S. Semi-Autonomous Surgical Robots Market: Strategic Recommendations for AI and Surgical Software Developers
TABLE 218: U.S. Semi-Autonomous Surgical Robots Market: Strategic Recommendations for Component and Technology Suppliers
TABLE 219: U.S. Semi-Autonomous Surgical Robots Market: Strategic Recommendations for New Entrants and Startups
TABLE 220: U.S. Semi-Autonomous Surgical Robots Market: U.S. Go-to-Market Strategy Considerations
TABLE 221: U.S. Semi-Autonomous Surgical Robots Market: Hospital Capital Procurement Strategy
TABLE 222: U.S. Semi-Autonomous Surgical Robots Market: ASC Commercialization Strategy
TABLE 223: U.S. Semi-Autonomous Surgical Robots Market: Clinical Evidence and Surgeon Adoption Strategy
TABLE 224: U.S. Semi-Autonomous Surgical Robots Market: FDA Regulatory Strategy Considerations
TABLE 225: U.S. Semi-Autonomous Surgical Robots Market: Product Positioning and Portfolio Expansion Guidance
TABLE 226: U.S. Semi-Autonomous Surgical Robots Market: Pricing and Recurring Revenue Strategy
TABLE 227: U.S. Semi-Autonomous Surgical Robots Market: Scope Limitation
TABLE 228: U.S. Semi-Autonomous Surgical Robots Market: Market Definition and Autonomy Classification Limitation
TABLE 229: U.S. Semi-Autonomous Surgical Robots Market: Data Use Limitation
TABLE 230: U.S. Semi-Autonomous Surgical Robots Market: Forecasting Limitation
TABLE 231: U.S. Semi-Autonomous Surgical Robots Market: Regulatory and Clinical Data Limitation
TABLE 232: U.S. Semi-Autonomous Surgical Robots Market: Legal Disclaimer
TABLE 233: U.S. Semi-Autonomous Surgical Robots Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Semi-Autonomous Surgical Robots Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Map
FIGURE 4: Semi-Autonomous Surgical Robotics Technology Boundary
FIGURE 5: Value Chain Analysis
FIGURE 6: Supply Chain Analysis
FIGURE 7: PESTEL Analysis
FIGURE 8: Porter’s Five Forces Analysis
FIGURE 9: Market Attractiveness Analysis
FIGURE 10: Market Dynamics
FIGURE 11: Innovation & Patent Landscape, 2021–2025
FIGURE 12: Clinical Workflow Economics Framework
FIGURE 13: Hospital Capital Procurement Decision Framework
FIGURE 14: U.S. Semi-Autonomous Surgical Robots Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 15: U.S. Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 16: U.S. Semi-Autonomous Surgical Robots Market Year-wise Growth Curve, 2021–2035
FIGURE 17: Installed Base and Procedure Utilization Framework
FIGURE 18: Recurring Revenue and Procedure Economics Framework
FIGURE 19: Hospital Robotics Program ROI Framework
FIGURE 20: AI, Computer Vision, and Surgical Digitalization Landscape
FIGURE 21: FDA Regulatory Pathway for Semi-Autonomous Surgical Robotics
FIGURE 22: CMS Reimbursement and Procedure Economics Framework
FIGURE 23: Component Segment Market Share Analysis, 2025 & 2035
FIGURE 24: Component Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Robotic Platforms and Hardware Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Software, AI, and Digital Planning Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Instruments, Accessories, and Disposables Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Services, Maintenance, and Clinical Training Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Surgical Application Segment Market Share Analysis, 2025 & 2035
FIGURE 30: Surgical Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Orthopedic and Joint Reconstruction Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Spine and Neurosurgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Urology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: General and Laparoscopic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Gynecologic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Other Surgical Applications Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Autonomy Function Segment Market Share Analysis, 2025 & 2035
FIGURE 38: Autonomy Function Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Active Constraint and Haptic Guidance Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Automated Planning, Registration, and Navigation Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Automated Instrument Positioning and Depth Control Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Supervised Tissue Resection and Ablation Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: AI-Assisted Intraoperative Workflow and Visualization Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 45: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Hospitals and Integrated Delivery Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Academic Medical Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Specialty Surgical Centers and Physician-Led Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Procurement & Commercial Model Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Procurement & Commercial Model Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Direct Capital Purchase Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Leasing and Rental Models Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Procedure-Based and Pay-Per-Use Models Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Integrated Delivery Network and Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Strategic Bundling and Portfolio-Based Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 58: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Regional Robotic Procedure Volume and Installed Base Comparison, 2025
FIGURE 60: West Region U.S. Semi-Autonomous Surgical Robots Market Share and Leading Players, 2025
FIGURE 61: West Region Market Share Analysis by State, 2025
FIGURE 62: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: California Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Washington Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Arizona Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Colorado Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Oregon Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Utah Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Nevada Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: New Mexico Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Idaho Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Montana Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Wyoming Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Alaska Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Hawaii Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Northeast Region U.S. Semi-Autonomous Surgical Robots Market Share and Leading Players, 2025
FIGURE 77: Northeast Region Market Share Analysis by State, 2025
FIGURE 78: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: New York Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Massachusetts Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: New Jersey Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Pennsylvania Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Connecticut Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Maine Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Vermont Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: New Hampshire Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Rhode Island Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Delaware Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: South Region U.S. Semi-Autonomous Surgical Robots Market Share and Leading Players, 2025
FIGURE 90: South Region Market Share Analysis by State, 2025
FIGURE 91: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Texas Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Florida Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Georgia Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: North Carolina Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Tennessee Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: South Carolina Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Alabama Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Mississippi Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Louisiana Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Arkansas Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Kentucky Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Oklahoma Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Virginia Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Maryland Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: West Virginia Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Midwest Region U.S. Semi-Autonomous Surgical Robots Market Share and Leading Players, 2025
FIGURE 108: Midwest Region Market Share Analysis by State, 2025
FIGURE 109: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Illinois Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Ohio Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Michigan Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Minnesota Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Indiana Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Wisconsin Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Missouri Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Iowa Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Kansas Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Nebraska Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: North Dakota Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: South Dakota Semi-Autonomous Surgical Robots Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 123: Company Positioning Matrix
FIGURE 124: Robotic Platform Breadth Benchmarking
FIGURE 125: Autonomy Capability Benchmarking
FIGURE 126: Installed Base and Procedure Utilization Benchmarking
FIGURE 127: Software, AI, and Recurring Revenue Benchmarking
FIGURE 128: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 129: Semi-Autonomous Surgical Robotics Innovation Roadmap
FIGURE 130: Future Market Scenario Analysis, 2026–2035
FIGURE 131: Disruptive Technologies Impact Matrix
FIGURE 132: Evolution from Robotic Assistance to Semi-Autonomy Roadmap
FIGURE 133: AI-Powered Surgical Intelligence Opportunity Map
FIGURE 134: Miniaturized and Handheld Robotics Adoption Roadmap
FIGURE 135: ASC Robotics Commercialization Roadmap
FIGURE 136: Emerging Business Trends Matrix
FIGURE 137: Investment Prioritization Matrix
FIGURE 138: Technology Readiness and Commercialization Matrix
FIGURE 139: Surgical Specialty Opportunity Matrix
FIGURE 140: Market White-Space Analysis
FIGURE 141: Strategic Growth Roadmap for U.S. Semi-Autonomous Surgical Robotics Companies
FIGURE 142: Hospital and IDN Adoption Strategy Framework
FIGURE 143: ASC Commercialization Strategy Framework
FIGURE 144: Clinical Evidence and Surgeon Adoption Framework
FIGURE 145: Go-to-Market Strategy Framework
FIGURE 146: Product Positioning and Portfolio Expansion Framework
FIGURE 147: Pricing and Recurring Revenue Strategy Framework
FIGURE 148: Report Scope, Autonomy Classification, and Disclaimer Framework